Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Inventory Average (2016 - 2018)

Theravance Biopharma (TBPH) has disclosed Inventory Average for 5 consecutive years, with $17.9 million as the latest value for Q3 2018.

  • Quarterly Inventory Average rose 30.84% to $17.9 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $17.9 million through Sep 2018, up 30.84% year-over-year, with the annual reading at $14.5 million for FY2017, 30.71% up from the prior year.
  • Inventory Average for Q3 2018 was $17.9 million at Theravance Biopharma, up from $17.6 million in the prior quarter.
  • The five-year high for Inventory Average was $17.9 million in Q3 2018, with the low at $9.6 million in Q2 2016.
  • Average Inventory Average over 5 years is $13.2 million, with a median of $12.7 million recorded in 2017.
  • The sharpest move saw Inventory Average dropped 22.8% in 2016, then skyrocketed 38.6% in 2018.
  • Over 5 years, Inventory Average stood at $13.8 million in 2014, then decreased by 19.98% to $11.1 million in 2015, then increased by 11.53% to $12.4 million in 2016, then increased by 29.91% to $16.0 million in 2017, then rose by 11.66% to $17.9 million in 2018.
  • According to Business Quant data, Inventory Average over the past three periods came in at $17.9 million, $17.6 million, and $17.0 million for Q3 2018, Q2 2018, and Q1 2018 respectively.